Overview
A covalently linked dimeric nonessential amino acid formed by the oxidation of cysteine. Two molecules of cysteine are joined together by a disulfide bridge to form cystine.
Indication
It has been claimed that L-cysteine has anti-inflammatory properties, that it can protect against various toxins, and that it might be helpful in osteoarthritis and rheumatoid arthritis. More research will have to be done before L-cysteine can be indicated for any of these conditions. Research to date has mostly been in animal models.
Associated Conditions
- Acne
- Alopecia
- Atrophic dermatitis
- Hair Damage
- Hair growth abnormal
- Nail growth abnormal
- Psoriasis
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/01/24 | Phase 3 | Not yet recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| PANTOGAR CAP | N/A | N/A | N/A | 4/17/2002 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| USANA Hepa+ | 330959 | Medicine | A | 3/10/2020 | |
| Wonderlab Liver Detox | 411271 | Medicine | A | 6/26/2023 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| AMINO-CERV | milex, a coopersurgical co. | 00137464 | Cream - Vaginal | 0.354 % | 12/31/1952 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| VAMIN 18 SIN ELECTROLITOS SOLUCION PARA PERFUSION | Fresenius Kabi España, S.A.U. | 59878 | SOLUCIÓN PARA PERFUSIÓN | Uso Hospitalario | Commercialized |
| VAMIN 14 SIN ELECTROLITOS SOLUCION PARA PERFUSION | Fresenius Kabi España, S.A.U. | 59885 | SOLUCIÓN PARA PERFUSIÓN | Uso Hospitalario | Commercialized |
| CRECIL 500 mg CAPSULAS DURAS | Laboratorios Vinas S.A. | 57896 | CÁPSULA DURA | Sin Receta | Commercialized |
| CISTINA 250 mg COMPRIMIDOS | La Quimica Medica S.A. | 32621 | COMPRIMIDO | Sin Receta | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.